Stroke, Vol 23, 995-999, Copyright © 1992 by American Heart Association
O Matsuo, K Okada, H Fukao, A Suzuki and S Ueshima
BACKGROUND AND PURPOSE: In the spontaneously hypertensive stroke-prone rat,
it is unclear whether plasminogen activator plays a role in the development
of stroke. The present study was undertaken to investigate brain levels of
plasminogen activator activity in spontaneously hypertensive stroke-prone
rats and Wistar-Kyoto rats. METHODS: Plasminogen activator was purified
from the brains of rats of both strains. The purification involved used
ammonium sulfate precipitation, gel filtration, a zinc chelate-Sepharose
column, and a concanavalin A- Sepharose column. Fraction I (0.15 M
KCl-soluble fraction) and fraction II (2 M KCl plus 6 M urea-soluble
fraction) were purified from both strains. RESULTS: Total plasminogen
activator activity in the original homogenates for fractions I and II
derived from spontaneously hypertensive stroke-prone rats was increased to
twice the level found in Wistar-Kyoto rats. The final product purified from
fractions I and II in both strains of rats revealed single bands of
plasminogen activator activity on enzymatic analysis with a molecular
weight of 72,000. The purified product had stronger S-2288 amidolytic
activity than S-2444 amidolytic activity, and it also displayed
fibrin-binding ability. CONCLUSIONS: The study demonstrated that there is
an increased content of plasminogen activator in the brains of
spontaneously hypertensive stroke-prone rats that might be related to the
development of stroke.
ARTICLES
Cerebral plasminogen activator activity in spontaneously hypertensive stroke-prone rats
Department of Physiology, Kinki University School of Medicine, Osakasayama City, Japan.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |